CLINICAL_TRIALS
trial_result
· 2023-10-30
Clinical Trial Update: Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-028/KEYNOTE-28) [Phase 1]
Summary
Phase 1 study of pembrolizumab in participants with advanced solid tumors has completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Solid Tumor | Phase 1 | Status: COMPLETED | Results posted: 2023-10-30